Cargando…
Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery
Glycosylation has a clear role in cancer initiation and progression, with numerous studies identifying distinct glycan features or specific glycoproteoforms associated with cancer. Common findings include that aggressive cancers tend to have higher expression levels of enzymes that regulate glycosyl...
Autores principales: | Doud, Emma H., Yeh, Elizabeth S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903044/ https://www.ncbi.nlm.nih.gov/pubmed/36740994 http://dx.doi.org/10.1177/15330338221148811 |
Ejemplares similares
-
Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
por: Zhang, Ying, et al.
Publicado: (2014) -
Mass Spectrometry-Based Glycoproteomics and Prostate Cancer
por: Gabriele, Caterina, et al.
Publicado: (2021) -
Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review
por: Zhong, Li, et al.
Publicado: (2021) -
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
por: Riley, Nicholas M., et al.
Publicado: (2020) -
Glycoproteomics-Based Identification of Cancer Biomarkers
por: Kim, Evelyn H., et al.
Publicado: (2011)